Direxion Shares ETF Trust > Direxion Shares ETF Trust
Direxion Daily S&P Biotech Bull 3X Shares
Exchange-Traded Fund
Inverse of a benchmark
Index Fund
Series ID: S000049373
LEI: 549300WNBLZ8IWC9IW36
SEC CIK: 1424958
$988.90M
Avg Monthly Net Assets
$1.25B
Total Assets
$220.85M
Total Liabilities
$1.03B
Net Assets
Direxion Daily S&P Biotech Bull 3X Shares is an Exchange-Traded Fund in Direxion Shares ETF Trust
from Direxion Shares ETF Trust,
based in New York,
United States of America.
The fund has one share class
and monthly net assets of $988.90M.
On April 1st, 2024 it reported 134 holdings, the largest
being DREYFUS GOVERNMENT CASH MANAGE (19.0%), GOLDMAN FINANCIAL (10.0%) and DREYFUS (3.4%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
|---|---|---|---|---|
| Direxion Daily S&P Biotech Bull 3X Shares | C000156149 | ARCX | LABU |
Holdings
From latest NPORT-P, filed April 1st, 2024 for period ending January 31st, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics Inc COM | Long | Equity-common | US | $1M | 82K | 0.14 |
| 89BIO INC (89bio Inc.) | Long | Equity-common | US | $4M | 436K | 0.42 |
| AbbVie Inc. COM USD0.01 | Long | Equity-common | US | $9M | 58K | 0.92 |
| Acadia Pharmaceuticals Inc COM USD0.0001 | Long | Equity-common | US | $11M | 411K | 1.03 |
| Achillion Pharmace SHS | Long | Equity-common | US | $0 | 103K | – |
| Adma Biologics Inc COM USD0.0001 | Long | Equity-common | US | $3M | 523K | 0.26 |
| Agios Pharmaceuticals Inc COM USD0.001 | Long | Equity-common | US | $3M | 147K | 0.32 |
| Akero Therapeutics Inc COM USD0.0001 | Long | Equity-common | US | $9M | 434K | 0.91 |
| Alector Inc COM USD0.0001 | Long | Equity-common | US | $1M | 183K | 0.11 |
| Alkermes PLC COM USD0.01 | Long | Equity-common | IE | $9M | 333K | 0.87 |
| Alnylam Pharmaceuticals Inc. COM USD0.01 | Long | Equity-common | US | $9M | 51K | 0.85 |
| ALPINE IMMUNE SCIENCES INC | Long | Equity-common | US | $2M | 77K | 0.20 |
| Amgen Inc. COM USD0.0001 | Long | Equity-common | US | $10M | 32K | 0.97 |
| Amicus Therapeutics Inc. COM STK USD0.01 | Long | Equity-common | US | $9M | 764K | 0.92 |
| Anavex Life Sciences Corp. USD0.001 | Long | Equity-common | US | $1M | 223K | 0.13 |
| Apellis Pharmaceuticals Inc COM USD0.0001 | Long | Equity-common | US | $9M | 137K | 0.84 |
| Arcellx Inc COMMON STOCK | Long | Equity-common | US | $7M | 107K | 0.64 |
| Arcturus Therapeutics Holdings Inc COM | Long | Equity-common | US | $4M | 109K | 0.35 |
| Arcus Biosciences Inc. COM USD0.0001 | Long | Equity-common | US | $4M | 241K | 0.35 |
| ARDELYX INC | Long | Equity-common | US | $12M | 1M | 1.12 |
| Arrowhead Pharmaceuticals Inc COM USD0.001 | Long | Equity-common | US | $11M | 351K | 1.09 |
| Avid Bioservices Inc COM USD0.001 | Long | Equity-common | US | $2M | 366K | 0.24 |
| Avidity Biosciences Inc. COM | Long | Equity-common | US | $2M | 188K | 0.22 |
| Beam Therapeutics Incorporation COM (Beam Therapeutics Inc.) | Long | Equity-common | US | $8M | 326K | 0.77 |
| BioCryst Pharmaceuticals Inc. COM USD0.01 | Long | Equity-common | US | $5M | 917K | 0.47 |
| Biogen Inc COM USD0.0005 | Long | Equity-common | US | $9M | 36K | 0.86 |
| Biohaven Ltd COM NPV | Long | Equity-common | VG | $12M | 261K | 1.12 |
| Biomarin Pharmaceutical Inc. COM USD0.001 | Long | Equity-common | US | $8M | 93K | 0.79 |
| BIOMEA FUSION INC | Long | Equity-common | US | $2M | 98K | 0.17 |
| Bluebird Bio Inc COM USD0.01 | Long | Equity-common | US | $1M | 1M | 0.12 |
| Blueprint Medicines Corporation COM USD0.001 | Long | Equity-common | US | $9M | 117K | 0.90 |
| Bridgebio Pharma Inc COM USD0.001 | Long | Equity-common | US | $9M | 265K | 0.88 |
| CABALETTA BIO INC | Long | Equity-common | US | $4M | 201K | 0.40 |
| Caredx Inc COM USD0.001 | Long | Equity-common | US | $2M | 183K | 0.15 |
| CARIBOU BIOSCIENCES INC | Long | Equity-common | US | $2M | 366K | 0.22 |
| Catalyst Pharmaceuticals Inc. COM STK USD0.001 | Long | Equity-common | US | $5M | 338K | 0.47 |
| Celldex Therapeutics Inc. COM USD0.001(POST REV SPLT | Long | Equity-common | US | $5M | 142K | 0.48 |
| Cerevel Therapeutics Holdings Inc COM | Long | Equity-common | US | $6M | 136K | 0.55 |
| Cogent Biosciences Inc. COM | Long | Equity-common | US | $1M | 277K | 0.12 |
| Crinetics Pharmaceuticals Inc. COM USD0.001 | Long | Equity-common | US | $9M | 235K | 0.83 |
| CRISPR Therapeutics AG COM CHF0.03 | Long | Equity-common | CH | $8M | 134K | 0.81 |
| Cytokinetics Inc COM USD0.001 | Long | Equity-common | US | $20M | 253K | 1.91 |
| Day One Biopharmaceuticals Inc. COM | Long | Equity-common | US | $3M | 227K | 0.33 |
| Deciphera Pharmaceuticals Inc COM USD0.01 | Long | Equity-common | US | $2M | 134K | 0.19 |
| Denali Therapeutics Inc COM USD0.01 | Long | Equity-common | US | $5M | 309K | 0.48 |
| DISC MEDICINE INC | Long | Equity-common | US | $3M | 38K | 0.24 |
| DREYFUS GOV'T CASH MGMT -INSTITUTIONAL CUSIP 262006208 DGCXX (#289) (DREYFUS GOVERNMENT CASH MANAGE) | Long | Short-term investment vehicle | US | $196M | – | 19.02 |
| DREYFUS TRSRY SECURITIES CASH MGMT | Long | Short-term investment vehicle | US | $35M | – | 3.39 |
| Dynavax Technologies Corp. COM USD0.001 | Long | Equity-common | US | $7M | 519K | 0.65 |
| DYNE THERAPEUTICS INC (Dyne Therapeutics Inc.) | Long | Equity-common | US | $3M | 158K | 0.33 |
| Editas Medicine Inc COM USD0.0001 | Long | Equity-common | US | $2M | 342K | 0.23 |
| Exact Sciences Corporation COM USD0.01 | Long | Equity-common | US | $9M | 133K | 0.84 |
| Exelixis, Inc. COM USD0.001 | Long | Equity-common | US | $9M | 392K | 0.83 |
| Geron Corp. COM USD0.001 | Long | Equity-common | US | $3M | 2M | 0.29 |
| Gilead Sciences, Inc. COM USD0.001 | Long | Equity-common | US | $9M | 109K | 0.83 |
| GOLDMAN FINL SQ TRSRY INST 506 (GOLDMAN FINANCIAL) | Long | Short-term investment vehicle | US | $104M | – | 10.02 |
| GOLDMAN SACHS FIN GOV 465 INSTITUT (GOLDMAN SACHS LIQ ES FD A) | Long | Short-term investment vehicle | US | $16M | – | 1.50 |
| Halozyme Therapeutics Inc COM USD0.001 | Long | Equity-common | US | $7M | 216K | 0.71 |
| IDEAYA Biosciences Inc. COM USD0.0001 | Long | Equity-common | US | $8M | 186K | 0.78 |
| IMMUNITYBIO INC | Long | Equity-common | US | $2M | 710K | 0.23 |
| ImmunoGen, Inc. COM USD0.01 | Long | Equity-common | US | $9M | 295K | 0.84 |
| Immunovant Inc COM | Long | Equity-common | US | $8M | 220K | 0.78 |
| Incyte Corporation. COM USD0.001 | Long | Equity-common | US | $9M | 158K | 0.90 |
| Inhibrx Inc. COM | Long | Equity-common | US | $4M | 99K | 0.37 |
| Insmed Inc COM USD0.01 | Long | Equity-common | US | $9M | 308K | 0.83 |
| Intellia Therapeutics Inc COM USD0.0001 | Long | Equity-common | US | $7M | 297K | 0.68 |
| Ionis Pharmaceuticals, Inc. COM USD0.001 | Long | Equity-common | US | $9M | 177K | 0.88 |
| Iovance Biotherapeutics Inc COM USD0.000041666 | Long | Equity-common | US | $9M | 1M | 0.90 |
| Ironwood Pharmaceuticals, Inc. COM CL A USD0.001 | Long | Equity-common | US | $10M | 674K | 0.93 |
| Karuna Therapeutics Inc COM USD0.0001 | Long | Equity-common | US | $13M | 42K | 1.27 |
| Keros Therapeutics Inc. COM | Long | Equity-common | US | $3M | 63K | 0.34 |
| Kiniksa Pharmaceuticals Ltd. COM USD0.000273235 CL A | Long | Equity-common | BM | $2M | 92K | 0.16 |
| Krystal Biotech Inc COM USD0.00001 | Long | Equity-common | US | $9M | 81K | 0.87 |
| Kura Oncology Incorporation COM USD0.0001 (Kura Oncology Inc.) | Long | Equity-common | US | $3M | 145K | 0.28 |
| Kymera Therapeutics Inc COM | Long | Equity-common | US | $4M | 115K | 0.37 |
| MACROGENICS INC | Long | Equity-common | US | $1M | 91K | 0.13 |
| Madrigal Pharmaceuticals Inc USD0.0001 | Long | Equity-common | US | $9M | 41K | 0.87 |
| Mannkind Corporation COM USD0.01 | Long | Equity-common | US | $3M | 785K | 0.25 |
| MiMedx Group Inc. COM USD0.001 | Long | Equity-common | US | $1M | 174K | 0.13 |
| Mirum Pharmaceuticals Inc. COM USD0.0001 | Long | Equity-common | US | $3M | 125K | 0.32 |
| Moderna Inc COM USD0.0001 | Long | Equity-common | US | $11M | 107K | 1.05 |
| Morphic Holding Inc. COM USD0.0001 | Long | Equity-common | US | $6M | 195K | 0.60 |
| Myriad Genetics Inc. COM USD0.01 | Long | Equity-common | US | $4M | 165K | 0.34 |
| Natera Incorporation COM USD0.0001 (Natera Inc.) | Long | Equity-common | US | $10M | 148K | 0.95 |
| Neurocrine Biosciences Inc COM USD0.001 | Long | Equity-common | US | $10M | 73K | 0.99 |
| NOVAVAX INC | Long | Equity-common | US | $6M | 2M | 0.60 |
| NUVALENT INC | Long | Equity-common | US | $9M | 122K | 0.89 |
| OmniAb Inc. USD0.0001 A (USD12.5 VESTING) | Long | Equity-common | US | $0 | 15K | – |
| OmniAb Inc. USD0.0001 A (USD15 VESTING) | Long | Equity-common | US | $0 | 15K | – |
| Protagonist Therapeutics Inc COM USD0.00001 | Long | Equity-common | US | $4M | 161K | 0.39 |
| Prothena Corporation PLC USD0.01 | Long | Equity-common | IE | $6M | 199K | 0.55 |
| PTC Therapeutics, Inc. COM USD0.001 | Long | Equity-common | US | $9M | 326K | 0.82 |
| RAPT Therapeutics Inc. COM | Long | Equity-common | US | $2M | 88K | 0.21 |
| Recursion Pharmaceuticals Inc CL A | Long | Equity-common | US | $9M | 971K | 0.88 |
| Regeneron Pharmaceuticals, Inc. COM USD0.001 | Long | Equity-common | US | $10M | 10K | 0.94 |
| Regenxbio Incorporation COM USD0.0001 (Regenxbio Inc.) | Long | Equity-common | US | $1M | 116K | 0.14 |
| Relay Therapeutics Inc COM | Long | Equity-common | US | $3M | 314K | 0.28 |
| Replimune Group Inc COM USD0.001 | Long | Equity-common | US | $3M | 445K | 0.33 |
| Revolution Medicines Inc COM | Long | Equity-common | US | $10M | 351K | 0.94 |
| Rhythm Pharmaceuticals Inc COM USD0.001 | Long | Equity-common | US | $5M | 117K | 0.50 |
| Rocket Pharmaceuticals Inc COM USD0.01 | Long | Equity-common | US | $6M | 200K | 0.56 |
| ROIVANT SCIENCES LTD | Long | Equity-common | BM | $9M | 877K | 0.85 |
| S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | Derivative-equity | US | $35M | – | 3.39 | |
| S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | Derivative-equity | US | $31M | – | 3.03 | |
| S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | Derivative-equity | US | $28M | – | 2.73 | |
| S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | Derivative-equity | US | $12M | – | 1.14 | |
| S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | Derivative-equity | US | $10M | – | 1.00 | |
| S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | Derivative-equity | US | $9M | – | 0.87 | |
| S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | Derivative-equity | US | $-4M | – | -0.37 | |
| Sage Therapeutics Inc COM USD0.0001 | Long | Equity-common | US | $8M | 295K | 0.73 |
| SANA BIOTECHNOLOGY INC | Long | Equity-common | US | $2M | 420K | 0.22 |
| Sarepta Therapeutics Inc COM USD0.0001 | Long | Equity-common | US | $12M | 99K | 1.14 |
| SCHOLAR ROCK HOLDING CORP (Scholar Rock Holding Corp.) | Long | Equity-common | US | $1M | 103K | 0.14 |
| Scilex Holding Co COM | Long | Equity-common | US | $1M | 620K | 0.10 |
| SOLENO THERAPEUTICS INC | Long | Equity-common | US | $2M | 50K | 0.22 |
| Springworks Therapeutics Inc COM USD0.0001 | Long | Equity-common | US | $6M | 139K | 0.59 |
| Syndax Pharmaceuticals Inc. COM USD0.0001 | Long | Equity-common | US | $8M | 387K | 0.77 |
| TG Therapeutics Inc COM USD0.001 | Long | Equity-common | US | $9M | 548K | 0.86 |
| Travere Therapeutics Inc COM | Long | Equity-common | US | $4M | 412K | 0.36 |
| Twist Bioscience Corporation COM USD0.00001 | Long | Equity-common | US | $7M | 220K | 0.69 |
| Ultragenyx Pharmaceuticals Inc COM USD0.001 | Long | Equity-common | US | $9M | 213K | 0.91 |
| Uniqure N.V. COM EUR0.05 | Long | Equity-common | NL | $2M | 354K | 0.19 |
| United Therapeutics Corporation COM USD0.01 | Long | Equity-common | US | $8M | 36K | 0.74 |
| Vaxcyte Inc COM | Long | Equity-common | US | $11M | 152K | 1.05 |
| VERA THERAPEUTICS INC (Vera Therapeutics Inc.) | Long | Equity-common | US | $6M | 164K | 0.58 |
| Veracyte Inc COM USD0.001 | Long | Equity-common | US | $4M | 153K | 0.37 |
| Vericel Corporation COM NPV | Long | Equity-common | US | $4M | 102K | 0.42 |
| Vertex Pharmaceuticals Incorporated COM USD0.01 | Long | Equity-common | US | $11M | 25K | 1.03 |
| Verve Therapeutics Inc COM | Long | Equity-common | US | $3M | 293K | 0.31 |
| VIKING THERAPEUTICS INC (Viking Therapeutics Inc.) | Long | Equity-common | US | $10M | 397K | 0.93 |
| VIR Biotechnology Inc COM | Long | Equity-common | US | $4M | 383K | 0.35 |
| Viridian Therapeutics Inc COM | Long | Equity-common | US | $4M | 194K | 0.36 |
| Xencor Inc COM USD0.01 | Long | Equity-common | US | $2M | 115K | 0.21 |
| Zentalis Pharmaceuticals Inc COM | Long | Equity-common | US | $4M | 346K | 0.40 |
Address
Direxion Shares ETF Trust
1301 Avenue of the Americas
28th Floor
New York
New York
10019
United States of America
Websites
Directors
David Driscoll
Kathleen Berkery
Carlyle Peake
Mary Jo Collins
Daniel O'Neill
Angela Brickl
Transfer Agents
THE BANK OF NEW YORK MELLON
Pricing Services
ICE DATA SERVICES
BLOOMBERG FINANCE L.P.
Custodians
THE BANK OF NEW YORK MELLON
Shareholder Servicing Agents
THE BANK OF NEW YORK MELLON
Admins
U.S. BANCORP FUND SERVICES, LLC
Brokers
BNY Mellon Capital Markets, LLC
ADM Investor Services, Inc.
BNP Paribas
Credit Suisse Securities (USA) LLC
Goldman Sachs & Co. LLC
Citibank, National Association
Pershing LLC
KOREA INVESTMENT AND SECURITIES CO., LTD
CL SECURITIES TAIWAN COMPANY LIMITED